Navigation Links
Some patients may not need insulin for long-term control of type 2 diabetes
Date:6/15/2008

Some patients with type 2 diabetes can control their disease for years yet avoid insulin injections by using multiple classes of oral diabetic medications, a new study found. The results were presented Sunday, June 15, at The Endocrine Society's 90th Annual Meeting in San Francisco.

Findings from the study contradict common beliefs about non-insulin diabetic medications, said principal investigator Arthur Swislocki, MD, of the Veterans Affairs (VA) Northern California Health Care System in Martinez. Oral diabetes medications help control blood glucose, or sugar, levels in people whose bodies still produce some insulin, as is true for many patients with type 2 diabetes.

"Generally, both patients and physicians believe that long-term use of oral diabetic medications is not possible because these drugs lose their effectiveness over time as the patient's pancreas fails," Swislocki said. "Our data suggest that some patients can remain in good glucose control for years using non-insulin, oral diabetic agents."

The study result is good news for people who need medical therapy for type 2 diabetes, according to Swislocki. "They may be able to delay or avoid the use of insulin," he said.

Some patients prefer pills over insulin injections because they are easier to use or because the patient fears needles or getting low blood sugar, as is possible with insulin treatment, he said.

Swislocki and his coworkers studied the VA medical records of 191 veterans (188 men and 3 women) with type 2 diabetes who received treatment beginning in 1992 and received follow-up for 15 consecutive years. Of these patients, 96 began treatment solely with oral drugs. The researchers found that 55 percent of the patients (53 of 96) who started treatment with oral diabetic agents were able to continue using them 15 years later and achieve good blood sugar control. A measure of long-term blood sugar controlhemoglobin A1cimproved from an average of nea
'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Nurses, Doctors, Patients to Protest Health Insurers at National Day of Action - June 19th
2. Joint distraction promotes structural repair in patients with severe knee osteoarthritis
3. 30 percent RA patients refractory to anti-TNFs achieve disease remission with tocilizumab plus metho
4. Abatacept and infliximab improve clinical response over time in methotrexate-refractory RA patients
5. Serum sodium predicts mortality 10 times higher in PAH patients
6. Syntermed licenses Emory imaging technology for improved evaluation of heart failure patients
7. Abbott Opens New State-of-the-Art R&D Facility to Help Bring Medicines to Patients Faster
8. Research shows patients must re-learn going from sitting to standing after total knee replacement
9. New self-management program offers significant benefits for arthritis patients with chronic pain
10. Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapies
11. Biogen Idecs baminercept alfa shows promise in patients with rheumatoid arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... tests may one day help predict survival and the course ... also called Lou Gehrig,s disease, Italian researchers report. , , ... how fast ALS is progressing are called albumin and creatinine. ... health, according to the U.S. National Library of Medicine. ...
(Date:7/22/2014)... Boston University School of Medicine (BUSM) and Boston ... received care through BMC,s Violence Intervention Advocacy Program ... and social needs of violently injured youthswere less ... life changing behaviors through connections to caring, steady, ... hope. These findings are reported in the journal ...
(Date:7/22/2014)... The European Bio stimulants Market report defines and segments ... forecast of revenue. The bio stimulants market in Europe ... 2013 to $940.6 million by 2018, at a CAGR ... the TOC of the Europe Bio stimulants Market report, ... , http://www.micromarketmonitor.com/market/europe-bio-stimulants-1315565884.html , Agriculture contributes to 10% ...
(Date:7/22/2014)... California (PRWEB) July 22, 2014 In ... women in recovery, the Marinello School of Beauty joined ... Addiction Treatment Center for a free “Make-over Day.” ... to be of service to the community, and The ... and renewed. They also gained some first-hand experience about ...
(Date:7/22/2014)... Ipswich, Mass. (PRWEB) July 22, 2014 ... of EBSCO Information Services , announces the ... to assist occupational health and safety professionals employed ... of chemicals and need to manage the impact ... , PoisonEXPERT provides access to relevant chemical-specific information ...
Breaking Medicine News(10 mins):Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 2Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 3Health News:Clients of BMC's violence interventional advocacy program find experience supportive 2Health News:Clients of BMC's violence interventional advocacy program find experience supportive 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 5Health News:The Discovery House 'Make-over Day' Adds Pampering To Recovery 2Health News:The Discovery House 'Make-over Day' Adds Pampering To Recovery 3Health News:PoisonEXPERT™ from ExPub Now Available 2Health News:PoisonEXPERT™ from ExPub Now Available 3
... FALLS CHURCH, Va. and CUMMAQUID, Mass., April ... with research analysis partner Cambashi Ltd, today invited,medical ... on current industry,challenges and practices. The survey asks ... and applications, and,performance., The research team is ...
... function, researchers report , , WEDNESDAY, April 23 (HealthDay News) -- ... embryonic stem cells into three types of human heart muscle ... in mice. , The findings have a number of implications, ... cells to test drugs. , "We have now a supply ...
... 2008 Shire plc (LSE: SHP, NASDAQ: SHPGY,), the global ... approval from the U.S. Food and Drug Administration (FDA) ... Deficit Hyperactivity Disorder (ADHD) in adults. VYVANSE, introduced ... children aged 6 to 12 years, is now the ...
... Florida,s elected leaders,received a message from thousands ... Governor Charlie Crist and legislative leaders not to,eliminate ... the state,s most,vulnerable citizens., Driven by ambulance ... gurney,the petitions ask Governor Crist, Senate President Ken ...
... announces the following Webcast:, What: Heska Corporation Invites You to ... Stockholders on the Web, When: Tuesday, May 6, @ 9:00 ... Stockholders link on the front ... Simply log on to the web at the ...
... Germany of a myocardial infarction is not higher for ... Deutsches rzteblatt International (Dtsch Arztebl Int 2008; 105(15): 279-85), ... disproved this widely held view. , ( http://www.aerzteblatt-international.de/v4/archiv/pdf.asp?id=59860 ... medical data from AOK (a large general statutory health ...
Cached Medicine News:Health News:Risk Management: Best Practices for Medical Device Profitability 2Health News:Embryonic Stem Cells Turned Into Three Types of Heart Cells 2Health News:FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults 2Health News:FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults 3Health News:FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults 4Health News:Thousands Sign Petitions Urging Governor Crist and Legislative Leaders to Save Healthcare Coverage for 40,000 Floridians 2Health News:Thousands Sign Petitions Urging Governor Crist and Legislative Leaders to Save Healthcare Coverage for 40,000 Floridians 3Health News:Webcast Alert: Heska Corporation's Annual Meeting of Stockholders Webcast 2
(Date:7/22/2014)... N.J. , July 22, 2014  Vernalis plc ... achievement of proof-of-concept (POC) for CCP-08, the third ... prescription cough cold collaboration. Under this collaboration, POC ... a successful human pilot comparative study against an ... achieving POC, Vernalis will make a milestone payment ...
(Date:7/21/2014)... 2014 McCord Research, Inc. was recently ... 8,796,315). This patent describes a method for accelerating ... the inventor, Dr. McCord, this method includes administering ... a composition of an effective amount of hydroxytyrosol ... blood, such that the administration of the combination ...
(Date:7/21/2014)... July 21, 2014  EHE International, the recognized leader ... nationwide physician network, today announced that Dignity Health Medical ... has been named an EHE-certified preventive care ... Las Vegas region now have greater access ... their health. "EHE is proud to ...
Breaking Medicine Technology:Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 2Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 3US Patent Office Grants McCord Research Endothelial Cell Treatment Patent 2EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2
... Acute Myeloid ... ... the U.S. Food & Drug Administration (FDA) has granted orphan,drug designation ... (AML)., Celator is currently preparing to conduct two randomized Phase ...
... in ,The Lancet, and Presented at ESC Congress-, ... new international,study, the GISSI Heart Failure (GISSI-HF) study, ... esters reduced all cause mortality and hospital,admissions for ... findings are published in this week,s online version ...
Cached Medicine Technology:Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4
... Adams compact II centrifuge ... small laboratory. Attached, durable cover ... seals to minimize aerosol emissions, ... low temperature rise, brushless motor, ...
... Powerful ventilated floor-standing centrifuge. Mobile space ... large choice of accessories, analog controls, ... & shutdown (JOUAN patented pendulum system), ... and temperature limitation, rugged motor, tough ...
... utilize the infinity-corrected optical system ... in cell checking. The CKX31 ... suited to routine applications in ... culture and embryology to immunology ...
Continuous rocking motion graphic display....
Medicine Products: